Steven J. Meyer

Steven J. Meyer discloses dealings in 2 companies, chiefly Insys Therapeutics, Inc. and Akorn Inc. Between 5 February 2016 and 3 March 2020, the trades on record add up to 29 filings.

Purchases make up the whole of the open-market record (8 purchases, €417k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 9 share grants and 12 option exercises. In 2020 alone, the filings show 2 purchases and no sales.

Half of the purchases are above €44k and half below. 2 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The newest entry dates from 4 March 2020: an open-market purchase of €13k, in Akorn Inc. Typically, a trade is published a median of 1 day after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.